International Symposium “Clinical Trials in a Globalised Society -Building an Effective Cancer Clinical Trials System-“
date : 5/25/2010

A symposium was held at the British Embassy in Tokyo on May 25, 2010, on the theme of “Clinical Trials in a Globalised Society: Building an Effective System for Cancer Clinical Trials.” The symposium was co-hosted by the Institute in cooperation with the British, American, and Korean Embassies.
Together with visiting experts from each country, over one hundred participants joined in active discussions on how each country is creating effective systems for the cancer domain and development of new medicines in the midst of the ongoing international standardization of clinical research and clinical trial systems.
In the Opening Address, British Ambassador David Warren, U.S. Ambassador John V. Roos, Republic of Korea Minister of Economic Affairs Soon-Taik Hwang, and Japan Cancer Society Goodwill Ambassador Dr. Agnes Chan, together with Institute chairman, Dr. Kiyoshi Kurokawa, greeted participants and stressed the importance of cooperation among the countries in order to deliver effective new medicines more quickly and safely.
During the following Plenary Session, each country’s clinical trial system was introduced by, respectively, Dr. Yung-Jue Bang, Vice President of Korea National Enterprise for Clinical Trials (KoNECT), Dr. Edward Trimble, Head of Gynecologic Cancer Therapeutics and Quality of Cancer Care Therapeutics, Clinical Investigations Branch, at the National Cancer Institute, and Professor Jonathan Ledermann of University College London Cancer Institute. Also, Dr. Toshio Miyata, Assistant Director of Research & Development in the Health Policy Bureau at the Ministry of Health, Labour and Welfare spoke on the current situation and future direction in Japan.
Two panel discussions then followed, exploring the themes of “Promoting International Collaboration in Cancer Clinical Trials” and “Collaboration with Patient Groups”, with active debate on how best to attain a system enabling patient-centered clinical trials while also promoting international collaboration.
To conclude the symposium, concrete ideas and proposals for the future were generated through a review of the day’s discussions and comments from participants. Mr. Kan Suzuki, Senior Vice Minister of Education, Culture, Sports, Science and Technology, then closed the event with a speech emphasizing the importance of clinical research and trials as part of the policy of “Life Innovation,” one of the administration’s growth strategies centered on the healthcare field.
With the continued need for both the improvement and globalization of the clinical research and trial systems, it is anticipated that the four countries will collaborate further in sharing best practices and investigating future issues. It is hoped, therefore, that this symposium can serve as a foundation for deepening discussion and common policy implementation.
Together with visiting experts from each country, over one hundred participants joined in active discussions on how each country is creating effective systems for the cancer domain and development of new medicines in the midst of the ongoing international standardization of clinical research and clinical trial systems.
In the Opening Address, British Ambassador David Warren, U.S. Ambassador John V. Roos, Republic of Korea Minister of Economic Affairs Soon-Taik Hwang, and Japan Cancer Society Goodwill Ambassador Dr. Agnes Chan, together with Institute chairman, Dr. Kiyoshi Kurokawa, greeted participants and stressed the importance of cooperation among the countries in order to deliver effective new medicines more quickly and safely.
During the following Plenary Session, each country’s clinical trial system was introduced by, respectively, Dr. Yung-Jue Bang, Vice President of Korea National Enterprise for Clinical Trials (KoNECT), Dr. Edward Trimble, Head of Gynecologic Cancer Therapeutics and Quality of Cancer Care Therapeutics, Clinical Investigations Branch, at the National Cancer Institute, and Professor Jonathan Ledermann of University College London Cancer Institute. Also, Dr. Toshio Miyata, Assistant Director of Research & Development in the Health Policy Bureau at the Ministry of Health, Labour and Welfare spoke on the current situation and future direction in Japan.
Two panel discussions then followed, exploring the themes of “Promoting International Collaboration in Cancer Clinical Trials” and “Collaboration with Patient Groups”, with active debate on how best to attain a system enabling patient-centered clinical trials while also promoting international collaboration.
To conclude the symposium, concrete ideas and proposals for the future were generated through a review of the day’s discussions and comments from participants. Mr. Kan Suzuki, Senior Vice Minister of Education, Culture, Sports, Science and Technology, then closed the event with a speech emphasizing the importance of clinical research and trials as part of the policy of “Life Innovation,” one of the administration’s growth strategies centered on the healthcare field.
With the continued need for both the improvement and globalization of the clinical research and trial systems, it is anticipated that the four countries will collaborate further in sharing best practices and investigating future issues. It is hoped, therefore, that this symposium can serve as a foundation for deepening discussion and common policy implementation.
Exhibition date:2010-05-25
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Public Comment Submission] “GX2040 Vision (Draft)” (January 26, 2025)
- [Public Comment Submission] “Third Phase of The Healthcare Policy (Draft)” (February 3, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
- [Public Comment Submission] “Plan for Global Warming Countermeasures (Draft)” (January 26, 2025)
Featured Posts
-
2025-02-12
[Registration Open] (Webinar) The 131st HGPI Seminar “The Policy Process of the Kyoto City Caregiver Ordinance” (March 19, 2025)
-
2025-03-03
[Registration Open] (Webinar) HGPI Special Seminar “Insights from Harvard Students on Fukushima’s Recover” (March 21, 2025 EDT | March 22, 2025 JST)
-
2025-03-17
[Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March, 17, 2025)
-
2025-03-17
[Announcement] HGPI Participates in the WHO Civil Society Commission (March 17, 2025)
-
2025-03-17
[Policy Recommendations] Dementia Project Information Packet for Local Government Officials “Dementia Policies for Our City: Taking the First Step in Promoting Future Measures for Dementia” (March 17, 2025)